Elevated PCID2 expression enhances malignancy, invasiveness, and metastatic potential, implicating PCID2 as a driver of cell cycle dysregulation and apoptosis resistance, thereby promoting tumor proliferation and invasion. Here, PCID2 is linked to neoplasm.